Concepedia

Shridhar S. Kulkarni

SS

Statistics

Publications

5

Citations

230

H-Index

5

Active since

2008

Affiliations

St. John's University(Current)

Shridhar S. Kulkarni is an author at St. John's University specializing in medicinal chemistry, drug discovery, and pharmacy.

ORCID

Publications per year

2008–2013

5

Publications

5

Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase

Tanaji T. Talele, Payal Arora, Shridhar S. Kulkarni et al. · Bioorganic & Medicinal Chemistry · 2010 · 81 citations

, , +16

The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains

Diane Hardej, Charles R. Ashby, Nikhil Khadtare et al. · European Journal of Medicinal Chemistry · 2010 · 56 citations

, , +12

Synthesis and SAR optimization of quinazolin-4(3H)-ones as poly(ADP-ribose)polymerase-1 inhibitors

Shridhar S. Kulkarni, Satyakam Singh, Janki R. Shah et al. · European Journal of Medicinal Chemistry · 2012 · 52 citations · Full text

, , +12

Identification of novel PARP-1 inhibitors by structure-based virtual screening

Kevin Hannigan, Shridhar S. Kulkarni, Volodymyr G. Bdzhola et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 24 citations · Full text

, , +14

CoMFA and HQSAR studies on 6,7-dimethoxy-4-pyrrolidylquinazoline derivatives as phosphodiesterase10A inhibitors

Shridhar S. Kulkarni, Maulik Patel, Tanaji T. Talele · Bioorganic & Medicinal Chemistry · 2008 · 17 citations · Full text

, , +11

1–5 of 5